# BETA Technologies, Inc.: financial statements, quarterly

BETA · NYSE · CIK 1784570 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/beta.md) · [Financials](/companies/beta/financials.md) · [Filings](/companies/beta/filings.md) · [Insiders](/companies/beta/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/beta/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3.1](/filings/0001628280-25-055234.md) | [4.4 d](/filings/0001628280-26-015838.md) | [9.6](/filings/0001628280-26-033914.md) | [6.0](/filings/0001628280-26-055982.md) | [8.9](/filings/0001628280-25-055234.md) | [11.1 d](/filings/0001628280-26-015838.md) | [10.1](/filings/0001628280-26-033914.md) | [14.7](/filings/0001628280-26-055982.md) |
| Cost of revenue | $m | [1.2](/filings/0001628280-25-055234.md) | [1.2 d](/filings/0001628280-26-015838.md) | [1.7](/filings/0001628280-26-033914.md) | [1.2](/filings/0001628280-26-055982.md) | [2.7](/filings/0001628280-25-055234.md) | [4.2 d](/filings/0001628280-26-015838.md) | [4.3](/filings/0001628280-26-033914.md) | [6.6](/filings/0001628280-26-055982.md) |
| Gross profit | $m | [1.9](/filings/0001628280-25-055234.md) | [3.2 d](/filings/0001628280-26-015838.md) | [7.9](/filings/0001628280-26-033914.md) | [4.8](/filings/0001628280-26-055982.md) | [6.2](/filings/0001628280-25-055234.md) | [6.9 d](/filings/0001628280-26-015838.md) | [5.8](/filings/0001628280-26-033914.md) | [8.0](/filings/0001628280-26-055982.md) |
| Research and development | $m | [54.0](/filings/0001628280-25-055234.md) | [60.8 d](/filings/0001628280-26-015838.md) | [57.9](/filings/0001628280-26-033914.md) | [58.0](/filings/0001628280-26-055982.md) | [56.4](/filings/0001628280-25-055234.md) | [89.4 d](/filings/0001628280-26-015838.md) | [91.7](/filings/0001628280-26-033914.md) | [122](/filings/0001628280-26-055982.md) |
| Operating income | $m | [(73.0)](/filings/0001628280-25-055234.md) | [(76.0) d](/filings/0001628280-26-015838.md) | [(78.0)](/filings/0001628280-26-033914.md) | [(79.3)](/filings/0001628280-26-055982.md) | [(80.6)](/filings/0001628280-25-055234.md) | [(135) d](/filings/0001628280-26-015838.md) | [(133)](/filings/0001628280-26-033914.md) | [(158)](/filings/0001628280-26-055982.md) |
| Interest expense | $m | [2.9](/filings/0001628280-25-055234.md) | [2.9 d](/filings/0001628280-26-015838.md) | [2.9](/filings/0001628280-26-033914.md) | [2.9](/filings/0001628280-26-055982.md) | [3.5](/filings/0001628280-25-055234.md) | [3.8 d](/filings/0001628280-26-015838.md) | [3.6](/filings/0001628280-26-033914.md) | [3.7](/filings/0001628280-26-055982.md) |
| Income tax | $m | [0.2](/filings/0001628280-25-055234.md) | [0.3 d](/filings/0001628280-26-015838.md) | [0.1](/filings/0001628280-26-033914.md) | [0.2](/filings/0001628280-26-055982.md) | [0.3](/filings/0001628280-25-055234.md) | [0.2 d](/filings/0001628280-26-015838.md) | [0.2](/filings/0001628280-26-033914.md) | [0.3](/filings/0001628280-26-055982.md) |
| Net income | $m | [(75.1)](/filings/0001628280-25-055234.md) | [(76.4) d](/filings/0001628280-26-015838.md) | [(78.3)](/filings/0001628280-26-033914.md) | [(80.4)](/filings/0001628280-26-055982.md) | [(437)](/filings/0001628280-25-055234.md) | [(150) d](/filings/0001628280-26-015838.md) | [(122)](/filings/0001628280-26-033914.md) | [(149)](/filings/0001628280-26-055982.md) |
| Diluted EPS | $ per share | [(1.81)](/filings/0001628280-25-055234.md) | not reported | [(1.98)](/filings/0001628280-26-033914.md) | [(2.02)](/filings/0001628280-26-055982.md) | [(9.83)](/filings/0001628280-25-055234.md) | not reported | [(0.53)](/filings/0001628280-26-033914.md) | [(0.64)](/filings/0001628280-26-055982.md) |
| Basic EPS | $ per share | [(1.81)](/filings/0001628280-25-055234.md) | not reported | [(1.98)](/filings/0001628280-26-033914.md) | [(2.02)](/filings/0001628280-26-055982.md) | [(9.83)](/filings/0001628280-25-055234.md) | not reported | [(0.53)](/filings/0001628280-26-033914.md) | [(0.64)](/filings/0001628280-26-055982.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [254](/filings/0001628280-26-015838.md) | not reported | [52.2](/filings/0001628280-25-055234.md) | [301](/filings/0001628280-26-015838.md) | [237](/filings/0001628280-26-033914.md) | [175](/filings/0001628280-26-055982.md) | [688](/filings/0001628280-25-055234.md) | [1,710](/filings/0001628280-26-055982.md) | [1,589](/filings/0001628280-26-033914.md) | [1,479](/filings/0001628280-26-055982.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [327](/filings/0001628280-26-015838.md) | not reported | not reported | [713](/filings/0001628280-25-055234.md) | [1,739](/filings/0001628280-26-055982.md) | [1,621](/filings/0001628280-26-033914.md) | [1,504](/filings/0001628280-26-055982.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | [666](/filings/0001628280-26-015838.md) | not reported | not reported | [1,069](/filings/0001628280-25-055234.md) | [2,106](/filings/0001628280-26-055982.md) | [2,013](/filings/0001628280-26-033914.md) | [1,933](/filings/0001628280-26-055982.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | [56.6](/filings/0001628280-26-015838.md) | not reported | not reported | [68.3](/filings/0001628280-25-055234.md) | [76.4](/filings/0001628280-26-055982.md) | [75.9](/filings/0001628280-26-033914.md) | [104](/filings/0001628280-26-055982.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [230](/filings/0001628280-26-015838.md) | not reported | not reported | [279](/filings/0001628280-25-055234.md) | [288](/filings/0001628280-26-055982.md) | [288](/filings/0001628280-26-033914.md) | [318](/filings/0001628280-26-055982.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | [149](/filings/0001628280-26-015838.md) | not reported | not reported | [179](/filings/0001628280-25-055234.md) | [180](/filings/0001628280-26-055982.md) | [178](/filings/0001628280-26-033914.md) | [175](/filings/0001628280-26-055982.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | [2.8](/filings/0001628280-26-015838.md) | not reported | not reported | [5.7](/filings/0001628280-25-055234.md) | [5.7](/filings/0001628280-26-055982.md) | [7.1](/filings/0001628280-26-033914.md) | [8.5](/filings/0001628280-26-055982.md) |
| Shareholders' equity | $m | [551](/filings/0001628280-26-015838.md) | [385](/filings/0001628280-26-015838.md) | [266](/filings/0001628280-25-055234.md) | [196](/filings/0001628280-25-055234.md) | [436](/filings/0001628280-26-055982.md) | [366](/filings/0001628280-26-055982.md) | [293](/filings/0001628280-26-055982.md) | [790](/filings/0001628280-25-055234.md) | [1,818](/filings/0001628280-26-055982.md) | [1,725](/filings/0001628280-26-055982.md) | [1,615](/filings/0001628280-26-055982.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(57.4) d](/filings/0001628280-26-015838.md) | [(58.3)](/filings/0001628280-26-033914.md) | [(56.3) d](/filings/0001628280-26-055982.md) | [(68.8) d](/filings/0001628280-25-055234.md) | [(84.4) d](/filings/0001628280-26-015838.md) | [(95.4)](/filings/0001628280-26-033914.md) | [(74.9) d](/filings/0001628280-26-055982.md) |
| Capital expenditure | $m | [21.8 d](/filings/0001628280-26-015838.md) | [6.7](/filings/0001628280-26-033914.md) | [6.0 d](/filings/0001628280-26-055982.md) | [13.0 d](/filings/0001628280-25-055234.md) | [19.8 d](/filings/0001628280-26-015838.md) | [24.2](/filings/0001628280-26-033914.md) | [41.1 d](/filings/0001628280-26-055982.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-26-015838.md) | not reported | not reported | not reported | [0.0 d](/filings/0001628280-26-015838.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | period not labelled (2024-09-30) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [45.3](/filings/0001628280-25-055234.md) | [45.6](/filings/0001628280-26-033914.md) | [45.8](/filings/0001628280-26-055982.md) | [45.9](/filings/0001628280-25-055234.md) | [230](/filings/0001628280-26-033914.md) | [232](/filings/0001628280-26-055982.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.